HomeInsightsDividend

Concord Biotech Ltd dividend

Concord Biotech Ltd dividend

download
stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

1.8 K

stocks traded

Last Updated time: 19 Jul 9.00 AM

Image

Concord Biotech Ltd

NSE: CONCORDBIO

DPS

8.75

Last updated : FY 2024

Key Highlights

    The Dividend per Share of Concord Biotech Ltd is ₹ 8.75 as of 2024 .a1#The Dividend Payout of Concord Biotech Ltd changed from 22.22 % on March 2019 to 30.03 % on March 2024 . This represents a CAGR of 5.15% over 6 years. a1#The Latest Trading Price of Concord Biotech Ltd is ₹ 1697 as of 18 Jul 15:30 .a1#The Market Cap of Concord Biotech Ltd changed from ₹ 15922 crore on March 2020 to ₹ 15922 crore on March 2024 . This represents a CAGR of 0.00% over 1 years. a1#The Revenue of Concord Biotech Ltd changed from ₹ 194.99 crore to ₹ 329.78 crore over 8 quarters. This represents a CAGR of 30.05% a1#The EBITDA of Concord Biotech Ltd changed from ₹ 78.62 crore to ₹ 142.9 crore over 8 quarters. This represents a CAGR of 34.82% a1#The Net Pr of Concord Biotech Ltd changed from ₹ 49.26 crore to ₹ 95.02 crore over 8 quarters. This represents a CAGR of 38.89% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Concord Biotech Ltd

Market Cap

17,798 Cr

EPS

28.5

P/E Ratio (TTM) *

59.8

P/B Ratio (TTM) *

11.7

DTE *

0.0

ROE *

20.2

ROCE *

27.0

Dividend Yield *

0.57

DPS *

8.75

Dividend Payout *

30.03

Ann.Dividend % *

875

* All values are consolidated

Last Updated time: 19 Jul 9.00 AM

* All values are consolidated

Last Updated time: 19 Jul 9.00 AM

×

Historical Dividend Payout of Concord Biotech Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Concord Biotech Ltd

Period
Mar '1922
Mar '2024
Mar '210
Mar '223
Mar '2330
Mar '2430

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PRICE

1697.35

-4.00 (-0.24%)

stock direction

Last updated : 18 Jul 15:30

SWOT Analysis Of Concord Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Concord Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Concord Biotech Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Concord Biotech Ltd

Period
Mar '200
Mar '210
Mar '220
Mar '230
Mar '2415922

* All values are a in crore

×

Historical Revenue of Concord Biotech Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Concord Biotech Ltd

Period
Jun '22195
Sep '22165
Dec '22250
Mar '23285
Jun '23208
Sep '23270
Dec '23252
Mar '24330

* All values are a in crore

×

Historical EBITDA of Concord Biotech Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Concord Biotech Ltd

Period
Jun '2279
Sep '2243
Dec '22119
Mar '23139
Jun '2385
Sep '23124
Dec '23117
Mar '24143

* All values are a in crore

×

Historical Net Profit of Concord Biotech Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Concord Biotech Ltd

Period
Jun '2249
Sep '2222
Dec '2277
Mar '2391
Jun '2354
Sep '2381
Dec '2378
Mar '2495

* All values are a in crore

About Concord Biotech Ltd

About Concord Biotech Ltd

    Concord Biotech Ltd was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based biopharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immuno-suppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India. Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products. Its API manufacturing facilities are located at Dholka and Limbasi, and formulations facility at Valthera in Gujarat. In 2000, the Company was acquired by the Promoter, Mr. Sudhir Vaid. In 2016, the Company launched formulation business in India as well as emerging markets, including Nepal, Mexico, Indonesia, Thailand, Ecuador, Kenya, Singapore and Paraguay, and have further expanded to the United States. It established a facility at Valthera, Gujarat. It set up a joint venture in Japan to grow business in 2018. In 2019, the Company received two ANDA approvals. It expanded their business into critical care segment in India. It commenced marketing of Mycophenolate Mofetil Capsules USP 250 mg. In 2020, Mycophenolate Sodium Tablets got launched in the US market. A second API manufacturing facility at Limbasi was launched, which commenced operations in July, 2021. As of March 31, 2022, the Company had 6 fermentation-based immunosuppressant APIs, including tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus and pimecrolimus. It had 3 manufacturing facilities in the state of Gujarat, India, comprising API manufacturing facilities in Dholka and Limbasi and a formulation manufacturing facility in Valthera, which were commercialized in 2000, 2021 and 2016, respectively. Their total annual installed fermentation capacity for APIs was 1,250 m3, as of March 31, 2022. It had a total of 41 manufacturing blocks and 387 reactors in the Dholka and Limbasi facilities. As of March 31, 2022, the annual installed production capacity of formulation facility in Valthera amounted to 522.64 million units, with an average dosage capability of 0.17 million tablets, 0.36 million capsules and 646.46 bottles of dry syrup per shift, which is defined as eight hours of production. The Company is planning to raise capital from Public by issuing o 20,925,652 Equity Shares through Offer for Sale.

Concord Biotech Ltd News Hub

News

Concord Biotech to conduct AGM

Concord Biotech announced that the 39th Annual General Meeting (AGM) of the company will b...

Read more

31 May 202416:57

News

Volumes spurt at Concord Biotech Ltd counter

Inox Wind Ltd, Sumitomo Chemical India Ltd, Doms Industries Ltd, Natco Pharma Ltd are amon...

Read more

28 May 202414:30

News

Board of Concord Biotech recommends final dividend

Concord Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

23 May 202419:01

News

Concord Biotech declare Quarterly Result

Concord Biotech will hold a meeting of the Board of Directors of the Company on 23 May 202...

Read more

16 May 202412:02

News

Concord Biotech receives GMP certificate from Brazilian Health Regulatory Agency

Concord Biotech announced that Brazilian Health Regulatory Agency (ANVISA) has Issued Cert...

Read more

06 Mar 202415:22

News

Concord Biotech gains after receiving GMP certificate with zero observations

The Ministry of Health Pharmacy and Poisons Board, Republic of Kenya had conducted inspect...

Read more

23 Feb 202411:45

FAQs for dividends of Concord Biotech Ltd

What is the current market price of Concord Biotech Ltd Ltd as of July 19, 2024?

The current market price of Concord Biotech Ltd Ltd stands at 1697.3 per share.

What dividend did Concord Biotech Ltd declare in the last fiscal year?

In the last fiscal year, Concord Biotech Ltd declared a dividend totaling ₹8.8.

What is the most recent dividend declared by Concord Biotech Ltd?

Concord Biotech Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Concord Biotech Ltd declared dividends in the current fiscal year

Concord Biotech Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Concord Biotech Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Concord Biotech Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199